Panel Discussion: Beyond the Slide: Tissue AI as the Anchor for Multimodal Biomarker Discovery & Global Deployment
11:20 am - Wednesday 7th October 2026
- One Frontier Model, For Every Stage of Drug Development: Discover how a unified ecosystem powered by a single frontier AI model streamlines biomarker discovery, clinical trial stratification, regulatory-grade diagnostics, and global deployment to pathology labs. Platform agnostic development under one roof – no need for algorithm hand-offs or tedious integrations before deployment
- De-Risking CDx Timelines With Tissue AI: AI-driven biomarker signal detection reduces trial enrollment risk and enables more informed decisions from less tissue — shortening Rx-Dx co-development time
- Redefining Global Pathology Routine: Moving tissue biomarkers from isolated reference labs to global clinical routine powered by our extensive CRO partnerships and an active lab network
